Table 4.
Distribution and standardized incidence rates (reference populations: Europe, US, world) by age, sex, and histological type, Gironde CNS Tumor Registry, 2000–2007
| 0–14 y |
15–24 y |
25–64 y |
65–84 y |
85 y and over |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | Standardized Rates/100 000 |
% | Standardized Rates/100 000 |
% | Standardized Rates/100 000 |
% | Standardized Rates/100 000 |
% | Standardized Rates/100 000 |
||||||||||||
| Europe | US | World | Europe | US | World | Europe | US | World | Europe | US | World | Europe | US | World | |||||||
| Neuroepithelial tumors | Men | 50.7 | 3.90 | 3.94 | 3.94 | 36.4 | 3.29 | 3.27 | 3.24 | 24.4 | 8.53 | 8.48 | 7.81 | 24.3 | 25.65 | 25.63 | 25.56 | 15.6 | 22.88 | 23.41 | 23.90 |
| Women | 30.7 | 2.58 | 2.50 | 2.49 | 24.2 | 2.11 | 2.13 | 2.13 | 16.5 | 5.72 | 5.52 | 4.94 | 22.9 | 17.33 | 17.29 | 17.12 | 18.9 | 10.52 | 10.48 | 10.43 | |
| All | 81.3 | 3.26 | 3.23 | 3.24 | 60.6 | 2.71 | 2.72 | 2.70 | 40.8 | 7.10 | 6.99 | 6.39 | 47.2 | 20.65 | 20.91 | 20.90 | 34.4 | 13.77 | 14.46 | 14.77 | |
| Meningeal tumors | Men | 4.0 | 0.33 | 0.31 | 0.31 | 3.0 | 0.27 | 0.27 | 0.26 | 9.3 | 3.35 | 3.23 | 2.84 | 8.7 | 8.94 | 9.31 | 8.84 | 13.3 | 21.76 | 22.54 | 23.52 |
| Women | 1.3 | 0.11 | 0.11 | 0.10 | 6.1 | 0.54 | 0.54 | 0.54 | 27.3 | 9.22 | 9.15 | 7.84 | 25.9 | 20.05 | 19.86 | 20.05 | 33.3 | 18.11 | 19.23 | 19.53 | |
| All | 5.3 | 0.22 | 0.21 | 0.21 | 9.1 | 0.40 | 0.40 | 0.40 | 36.6 | 6.34 | 6.22 | 5.32 | 34.6 | 15.61 | 15.29 | 15.03 | 46.7 | 19.07 | 20.25 | 20.81 | |
| Cranial and spinal nerve tumors | Men | 2.7 | 0.18 | 0.20 | 0.20 | 6.1 | 0.55 | 0.55 | 0.53 | 9.6 | 3.40 | 3.35 | 3.08 | 2.9 | 3.35 | 3.11 | 3.41 | 1.1 | 1.98 | 2.02 | 2.29 |
| Women | 1.3 | 0.11 | 0.11 | 0.11 | 7.6 | 0.67 | 0.66 | 0.66 | 7.5 | 2.49 | 2.51 | 2.28 | 4.5 | 3.85 | 3.65 | 4.03 | 1.1 | 0.79 | 0.64 | 0.69 | |
| All | 4.0 | 0.15 | 0.15 | 0.15 | 13.6 | 0.61 | 0.60 | 0.60 | 17.1 | 2.94 | 2.93 | 2.68 | 7.4 | 3.65 | 3.42 | 3.75 | 2.2 | 1.10 | 1.07 | 1.21 | |
| Lymphomas | Men | 0.0 | 0.00 | 0.00 | 0.00 | 0.0 | 0.00 | 0.00 | 0.00 | 1.1 | 0.39 | 0.39 | 0.34 | 2.3 | 2.32 | 2.46 | 2.26 | 2.2 | 3.55 | 4.02 | 4.12 |
| Women | 0.0 | 0.00 | 0.00 | 0.00 | 0.0 | 0.00 | 0.00 | 0.00 | 1.2 | 0.42 | 0.40 | 0.35 | 2.6 | 2.05 | 1.97 | 2.06 | 4.4 | 2.71 | 2.89 | 2.99 | |
| All | 0.0 | 0.00 | 0.00 | 0.00 | 0.0 | 0.00 | 0.00 | 0.00 | 2.3 | 0.40 | 0.39 | 0.34 | 4.9 | 2.16 | 2.18 | 2.15 | 6.7 | 2.93 | 3.24 | 3.35 | |
| Other tumors | Men | 4.0 | 0.31 | 0.31 | 0.31 | 10.6 | 0.96 | 0.96 | 0.95 | 1.5 | 0.53 | 0.55 | 0.54 | 2.0 | 1.80 | 2.16 | 1.70 | 3.3 | 4.06 | 5.38 | 4.52 |
| Women | 5.3 | 0.41 | 0.44 | 0.43 | 6.1 | 0.53 | 0.53 | 0.52 | 1.6 | 0.58 | 0.55 | 0.54 | 3.8 | 2.65 | 2.84 | 2.50 | 6.7 | 3.84 | 3.85 | 3.88 | |
| All | 9.3 | 0.36 | 0.37 | 0.37 | 16.7 | 0.75 | 0.75 | 0.74 | 3.1 | 0.56 | 0.55 | 0.54 | 5.8 | 2.31 | 2.54 | 2.14 | 10.0 | 3.90 | 4.32 | 4.09 | |